Search Results for "Tingkatan Satu Sejarah Nota"

23:05 EST 26th February 2015 | BioPortfolio

Matching Channels

None

Matching News

Don't worry, be happy: Just go to bed earlier

When you go to bed, and how long you sleep at a time, might actually make it difficult for you to stop worrying. So say Jacob Nota and Meredith Coles of Binghamton University in the US, who found that...

Don't worry, be happy; just go to bed earlier

(Binghamton University) When you go to bed and how long you sleep at a time might actually make it difficult for you to stop worrying, according to researchers at Binghamton University. The study, led...

ValiRx CEO on upcoming trial

Dr Satu Vainikka, chief executive of ValiRx (LON:VAL), talks to Proactive Investors about the cancer drug group’s upcoming trial, having just received the go-ahead. The Phase I/II study is for V...

Unusual host preference of a moth species could be useful for biological control

(Pensoft Publishers) A team of Iranian researchers from the Rice Research Institute of Iran have discovered that Gynnodomorpha permixtana, a well-known moth species from Europe and Asia, has changed i...

ValiRx expects first results from prostate drug trial in first quarter of next year

Drug developer ValiRx (LON:VAL) said it hopes to have the first results from its phase I/II study on its key asset, VAL201, in the first quarter of next year. The data will relate to the safety and to...

Better Sleep Could Help Those Overwhelmed By Negative Thoughts

Chuck Bednar for redOrbit.com - Your Universe Online Those who go to bed extremely late at night and sleep for shorter periods of time are more likely to feel more consumed by worry, researchers from...

ValiRx's equity swap agreement with Yorkville comes to an end

ValiRx (LON:VAL) said its equity swap funding arrangement with Yorkville has been terminated early. The arrangement was entered into at the end of 2013 and has been exercised in full by agreement betw...

ValiRx shares lifted as VAL201 trial progresses on schedule

Cancer focused biopharma group ValiRx (LON:VAL) shares were lifted as it said the Phase I/II study for VAL201 is progressing on schedule. The first outcomes from the first cohort are anticipated durin...

Matching PubMed Articles

PET imaging of prostate tumors with (18) F-Al-NOTA-MATBBN.

Overexpression of the gastrin-releasing peptide receptor (GRPR) in prostate cancer provides a promising target for detection the disease. MATBBN is a new bombesin analog originating from the GRPR anta...

A 67/68Ga-labeling agent that liberates 67/68Ga-NOTA-methionine by lysosomal proteolysis of parental low molecular weight polypeptides to reduce renal radioactivity levels.

The renal localization of gallium-67 or gallium-68 (67/68Ga)-labeled low molecular weight (LMW) probes such as peptides and antibody fragments constitutes a problem in targeted imaging. Wu et al. prev...

Comparison of 18F-AIF-NOTA-PRGD2 and 18F-FDG Uptake in Lymph Node Metastasis of Differentiated Thyroid Cancer.

A widespread application of integrin αvβ3 imaging has been emerging in both pre-clinical and clinical studies. But few studies reported its value as compared with 18F-FDG PET, especially for differe...

The Effect of Mini-PEG-Based Spacer Length on Binding and Pharmacokinetic Properties of a 68Ga-Labeled NOTA-Conjugated Antagonistic Analog of Bombesin.

The overexpression of gastrin-releasing peptide receptor (GRPR) in cancer can be used for peptide-receptor mediated radionuclide imaging and therapy. We have previously shown that an antagonist analog...

PET of Follicle-Stimulating Hormone Receptor: Broad Applicability to Cancer Imaging.

Follicle-stimulating hormone receptor (FSHR) is selectively overexpressed by the vascular endothelium in a wide variety of tumors and confirmed to play critical roles in angiogenesis, tumor invasion, ...

Search Whole site using Google

Loading
Search BioPortfolio:
Loading
Advertisement
Advertisement
Advertisement Advertisement